HESTER BIOSCIENCES
Back to Balance Sheet
|
HESTER BIOSCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹158 Cr | ₹202 Cr | ₹254 Cr | ₹233 Cr | ₹198 Cr |
What is the latest Total Non-Current Liabilities ratio of HESTER BIOSCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹158 Cr |
| Mar2025 | ₹202 Cr |
| Mar2024 | ₹254 Cr |
| Mar2023 | ₹233 Cr |
| Mar2022 | ₹198 Cr |
How is Total Non-Current Liabilities of HESTER BIOSCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹158 Cr | -21.77 | |
| Mar2025 | ₹202 Cr | -20.65 | |
| Mar2024 | ₹254 Cr | 9.14 | |
| Mar2023 | ₹233 Cr | 17.61 | |
| Mar2022 | ₹198 Cr | - | |
Compare Total Non-Current Liabilities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,994.2 Cr | 0.1% | 8.8% | 39.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 0.1% |
8.8% |
39.7% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses